A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report. Issue 9 (18th September 2021)

• Record Type: Journal Article
• Authors: Takeuchi, Takaya; Matsuura, Yunosuke; Yamamura, Yoshimasa; Ohkusu, Momoko; Koyama, Shohei; Kawaguchi, Takeshi; Akaki Nagayasu, Mayumi; Komatsu, Hiroyuki; Okayama, Akihiko; Ishikawa, Tetsunori; Atsumi, Tatsuya; Kitamura, Kazuo
• Is Part Of: Clinical case reports. Volume 9:Issue 9(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-09-18
• Subjects: anti‐thrombotic therapy -- immune thrombocytopenia -- venous thromboembolism; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.4805
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: Patients with immune thrombocytopenia have increased risks of bleeding and thrombosis. The acute‐phase treatment for venous thromboembolism complicated with severe immune thrombocytopenia involves a "platelet dilemma" in therapeutic decision‐making. Abstract : Patients with immune thrombocytopenia have increased risks of bleeding and thrombosis. The acute‐phase treatment for venous thromboembolism complicated with severe immune thrombocytopenia involves a "platelet dilemma" in therapeutic decision‐making.